| 10197965
|
Structure-based design, synthesis, and biological evaluation of irreversible human rhinovirus 3C protease inhibitors. 4. Incorporation of P1 lactam moieties as L-glutamine replacements. |
J Med Chem |
1999 |
Dragovich PS;Prins TJ;Zhou R;Webber SE;Marakovits JT;Fuhrman SA;Patick AK;Matthews DA;Lee CA;Ford CE;Burke BJ;Rejto PA;Hendrickson TF;Tuntland T;Brown EL;Meador JW 3rd;Ferre RA;Harr JE;Kosa MB;Worland ST |
View
More |
| 10500114
|
Structure-assisted design of mechanism-based irreversible inhibitors of human rhinovirus 3C protease with potent antiviral activity against multiple rhinovirus serotypes. |
Proc Natl Acad Sci U S A |
1999 |
Matthews DA;Dragovich PS;Webber SE;Fuhrman SA;Patick AK;Zalman LS;Hendrickson TF;Love RA;Prins TJ;Marakovits JT;Zhou R;Tikhe J;Ford CE;Meador JW;Ferre RA;Brown EL;Binford SL;Brothers MA;DeLisle DM;Worland ST |
View
More |
| 10508022
|
In vitro antiviral activity of AG7088, a potent inhibitor of human rhinovirus 3C protease. |
Antimicrob Agents Chemother |
1999 |
Patick AK;Binford SL;Brothers MA;Jackson RL;Ford CE;Diem MD;Maldonado F;Dragovich PS;Zhou R;Prins TJ;Fuhrman SA;Meador JW;Zalman LS;Matthews DA;Worland ST |
View
More |
| 10770757
|
Inhibition of human rhinovirus-induced cytokine production by AG7088, a human rhinovirus 3C protease inhibitor. |
Antimicrob Agents Chemother |
2000 |
Zalman LS;Brothers MA;Dragovich PS;Zhou R;Prins TJ;Worland ST;Patick AK |
View
More |
| 10974374
|
In vitro activity of pleconaril and AG7088 against selected serotypes and clinical isolates of human rhinoviruses. |
Antiviral Res |
2000 |
Kaiser L;Crump CE;Hayden FG |
View
More |
| 11166856
|
The treatment of rhinovirus infections: progress and potential. |
Antiviral Res |
2001 |
Turner RB |
View
More |
| 11249711
|
AG-7088 Pfizer. |
Curr Opin Investig Drugs |
2000 |
Witherell G |
View
More |
| 11302940
|
Liquid chromatography-mass spectrometry and liquid chromatography-NMR characterization of in vitro metabolites of a potent and irreversible peptidomimetic inhibitor of rhinovirus 3C protease. |
Drug Metab Dispos |
2001 |
Zhang KE;Hee B;Lee CA;Liang B;Potts BC |
View
More |
| 11796347
|
Pharmacokinetics and safety of an antirhinoviral agent, ruprintrivir, in healthy volunteers. |
Antimicrob Agents Chemother |
2002 |
Hsyu PH;Pithavala YK;Gersten M;Penning CA;Kerr BM |
View
More |
| 12746549
|
Coronavirus main proteinase (3CLpro) structure: basis for design of anti-SARS drugs. |
Science |
2003 |
Anand K;Ziebuhr J;Wadhwani P;Mesters JR;Hilgenfeld R |
View
More |
| 1318383
|
Binding of an antiviral agent to a sensitive and a resistant human rhinovirus. Computer simulation studies with sampling of amino acid side-chain conformation. I. Mapping the rotamers of residue 188 of viral protein 1. |
J Mol Biol |
1992 |
Wade RC;McCammon JA |
View
More |
| 1318384
|
Binding of an antiviral agent to a sensitive and a resistant human rhinovirus. Computer simulation studies with sampling of amino acid side-chain conformations. II. Calculation of free-energy differences by thermodynamic integration. |
J Mol Biol |
1992 |
Wade RC;McCammon JA |
View
More |
| 14638501
|
Phase II, randomized, double-blind, placebo-controlled studies of ruprintrivir nasal spray 2-percent suspension for prevention and treatment of experimentally induced rhinovirus colds in healthy volunteers. |
Antimicrob Agents Chemother |
2003 |
Hayden FG;Turner RB;Gwaltney JM;Chi-Burris K;Gersten M;Hsyu P;Patick AK;Smith GJ 3rd;Zalman LS |
View
More |
| 15493396
|
The efficacy of valacyclovir in preventing recurrent herpes simplex virus infections associated with dental procedures. |
J Am Dent Assoc |
2004 |
Miller CS;Cunningham LL;Lindroth JE;Avdiushko SA |
View
More |
| 15673742
|
Conservation of amino acids in human rhinovirus 3C protease correlates with broad-spectrum antiviral activity of rupintrivir, a novel human rhinovirus 3C protease inhibitor. |
Antimicrob Agents Chemother |
2005 |
Binford SL;Maldonado F;Brothers MA;Weady PT;Zalman LS;Meador JW 3rd;Matthews DA;Patick AK |
View
More |
| 16206603
|
[Combined therapy with quinapril, an ACE inhibitor, and valsartan, a type 1 angiotensin II receptors blocker, for moderate chronic cardiac failure may raise the degree of neurohormonal block and improve 24-h heart rate variability compared to the effect of monotherapy (data from the trial SADKO-CHF)]. |
Ter Arkh |
2005 |
Skvortsov AA;Nasonova SN;Sychev AV;Arbolishvili GN;Baklanova NA;Mareev VIu;Belenkov IuN |
View
More |
| 16883264
|
[Effects of long term therapy with angiotensin converting enzyme inhibitor quinapril, antagonist of receptors to angiotensin II valsartan, and combination of quinapril and valsartan in patients with moderate chronic heart failure. Main results of the SADKO-CHF study]. |
Kardiologiia |
2006 |
Skvortsov AA;Nasonova SN;Sychev AV;Orlova IaA;Baklanova NA;Masenko VP;Mareev VIu;Belenkov IuN |
View
More |
| 17076227
|
[Is triple combination of different neurohormonal modulators recommended for treatment of mild-to-moderate congestive heart failure patients? (Results of SADKO-CHF study). Part 2]. |
Ter Arkh |
2006 |
Skvortsov AA;Mareev VIu;Nasonova SN;Sychev AV;Arbolishvili GN;Baklanova NA;Masenko VP;Belenkov IuN |
View
More |
| 17078211
|
[Is triple combination of different neurohormonal modulators recommended for treatment of mild-to-moderate congestive heart failure patients? (Results of Sadko-CHF study)]. |
Ter Arkh |
2006 |
Skvortsov AA;Mareev VIu;Nasonova SN;Sychev AV;Arbolishvili GN;Baklanova NA;Masenko VP;Belenkov IuN |
View
More |
| 17485072
|
Development of potent inhibitors of the coxsackievirus 3C protease. |
Biochem Biophys Res Commun |
2007 |
Lee ES;Lee WG;Yun SH;Rho SH;Im I;Yang ST;Sellamuthu S;Lee YJ;Kwon SJ;Park OK;Jeon ES;Park WJ;Kim YC |
View
More |
| 17536444
|
Herpes simplex virus: it\'s more than a cold sore. |
Mo Med |
2007 |
Swearingen JA;Ailor SK |
View
More |
| 17908951
|
In vitro resistance study of rupintrivir, a novel inhibitor of human rhinovirus 3C protease. |
Antimicrob Agents Chemother |
2007 |
Binford SL;Weady PT;Maldonado F;Brothers MA;Matthews DA;Patick AK |
View
More |
| 20066739
|
Rupintrivir is a promising candidate for treating severe cases of Enterovirus-71 infection. |
World J Gastroenterol |
2010 |
Zhang XN;Song ZG;Jiang T;Shi BS;Hu YW;Yuan ZH |
View
More |
| 21795339
|
Enterovirus 71 and coxsackievirus A16 3C proteases: binding to rupintrivir and their substrates and anti-hand, foot, and mouth disease virus drug design. |
J Virol |
2011 |
Lu G;Qi J;Chen Z;Xu X;Gao F;Lin D;Qian W;Liu H;Jiang H;Yan J;Gao GF |
View
More |
| 21813612
|
Crystal structures of enterovirus 71 3C protease complexed with rupintrivir reveal the roles of catalytically important residues. |
J Virol |
2011 |
Wang J;Fan T;Yao X;Wu Z;Guo L;Lei X;Wang J;Wang M;Jin Q;Cui S |
View
More |
| 21835784
|
Structural basis for antiviral inhibition of the main protease, 3C, from human enterovirus 93. |
J Virol |
2011 |
Costenaro L;Kaczmarska Z;Arnan C;Janowski R;Coutard B;Sola M;Gorbalenya AE;Norder H;Canard B;Coll M |
View
More |
| 21889905
|
Current management and recommendations for access to antiviral therapy of herpes labialis. |
J Clin Virol |
2012 |
Cunningham A;Griffiths P;Leone P;Mindel A;Patel R;Stanberry L;Whitley R |
View
More |
| 23295352
|
Rupintrivir is a promising candidate for treating severe cases of enterovirus-71 infection: evaluation of antiviral efficacy in a murine infection model. |
Antiviral Res |
2013 |
Zhang X;Song Z;Qin B;Zhang X;Chen L;Hu Y;Yuan Z |
View
More |
| 23549610
|
The newly emerged SARS-like coronavirus HCoV-EMC also has an "Achilles\' heel": current effective inhibitor targeting a 3C-like protease. |
Protein Cell |
2013 |
Ren Z;Yan L;Zhang N;Guo Y;Yang C;Lou Z;Rao Z |
View
More |
| 23633597
|
Structures of Enterovirus 71 3C proteinase (strain E2004104-TW-CDC) and its complex with rupintrivir. |
Acta Crystallogr D Biol Crystallogr |
2013 |
Wu C;Cai Q;Chen C;Li N;Peng X;Cai Y;Yin K;Chen X;Wang X;Zhang R;Liu L;Chen S;Li J;Lin T |
View
More |
| 24366736
|
Multiple classes of antiviral agents exhibit in vitro activity against human rhinovirus type C. |
Antimicrob Agents Chemother |
2014 |
Mello C;Aguayo E;Rodriguez M;Lee G;Jordan R;Cihlar T;Birkus G |
View
More |
| 25001952
|
Brain-derived neurotrophic factor (BDNF) Val66Met polymorphism affects sympathetic tone in a gender-specific way. |
Psychoneuroendocrinology |
2014 |
Chang CC;Chang HA;Chen TY;Fang WH;Huang SY |
View
More |
| 25261311
|
Proteases of human rhinovirus: role in infection. |
Methods Mol Biol |
2015 |
Jensen LM;Walker EJ;Jans DA;Ghildyal R |
View
More |
| 2541225
|
Computer simulation study of the binding of an antiviral agent to a sensitive and a resistant human rhinovirus. |
J Comput Aided Mol Des |
1989 |
Lybrand TP;McCammon JA |
View
More |
| 25792507
|
Peptidomimetic ethyl propenoate covalent inhibitors of the enterovirus 71 3C protease: a P2-P4 study. |
J Enzyme Inhib Med Chem |
2016 |
Ang MJ;Lau QY;Ng FM;Then SW;Poulsen A;Cheong YK;Ngoh ZX;Tan YW;Peng J;Keller TH;Hill J;Chu JJ;Chia CS |
View
More |
| 26055377
|
The enterovirus 3C protease inhibitor SG85 efficiently blocks rhinovirus replication and is not cross-resistant with rupintrivir. |
Antimicrob Agents Chemother |
2015 |
Lacroix C;George S;Leyssen P;Hilgenfeld R;Neyts J |
View
More |
| 29530860
|
Selection and Characterization of Rupintrivir-Resistant Norwalk Virus Replicon Cells In Vitro. |
Antimicrob Agents Chemother |
2018 |
Kitano M;Hosmillo M;Emmott E;Lu J;Goodfellow I |
View
More |
| 30091268
|
Progression of transthyretin (TTR) amyloidosis in donors and recipients after domino liver transplantation-a prospective single-center cohort study. |
Transpl Int |
2018 |
Vollmar J;Schmid JC;Hoppe-Lotichius M;Barreiros AP;Azizi M;Emrich T;Geber C;Schad A;Weyer V;Otto G;Heise M;Mittler J;Birklein F;Lang H;Galle PR;Zimmermann T |
View
More |
| 31640701
|
Rupintrivir reduces RV-induced TH-2 cytokine IL-4 in precision-cut lung slices (PCLS) of HDM-sensitized mice ex vivo. |
Respir Res |
2019 |
Danov O;Lasswitz L;Obernolte H;Hesse C;Braun A;Wronski S;Sewald K |
View
More |
| 32103448
|
Structure of the HRV-C 3C-Rupintrivir Complex Provides New Insights for Inhibitor Design. |
Virol Sin |
2020 |
Yuan S;Fan K;Chen Z;Sun Y;Hou H;Zhu L |
View
More |
| 34181859
|
Rhinovirus-induced Human Lung Tissue Responses Mimic Chronic Obstructive Pulmonary Disease and Asthma Gene Signatures. |
Am J Respir Cell Mol Biol |
2021 |
Wronski S;Beinke S;Obernolte H;Belyaev NN;Saunders KA;Lennon MG;Schaudien D;Braubach P;Jonigk D;Warnecke G;Zardo P;Fieguth HG;Wilkens L;Braun A;Hessel EM;Sewald K |
View
More |
| 34506130
|
Pan-3C Protease Inhibitor Rupintrivir Binds SARS-CoV-2 Main Protease in a Unique Binding Mode. |
Biochemistry |
2021 |
Lockbaum GJ;Henes M;Lee JM;Timm J;Nalivaika EA;Thompson PR;Kurt Yilmaz N;Schiffer CA |
View
More |
| 34960671
|
RIPK1 Is Cleaved by 3C Protease of Rhinovirus A and B Strains and Minor and Major Groups. |
Viruses |
2021 |
Croft SN;Walker EJ;Ghildyal R |
View
More |
| 4341555
|
Susceptibility to, and production of interferon by rhinovirus. 1. |
Proc Soc Exp Biol Med |
1972 |
Fiala M |
View
More |
| 4365491
|
Inhibition of rhinovirus RNA synthesis in diploid cells by a substituted guanidine compound having a different mode of action from guanidine. |
J Gen Virol |
1974 |
Koliais SI Dimmock NJ |
View
More |
